Posts

FDA grants authorization to Invitae DNA test to identif...

The healthcare sector is undergoing rapid changes, with genetic testing leading ...

Lumicell co-founder wins Nobel Prize in Chemistry

The co-founder of a fluorescence-guided imaging technology firm has been awarde...

Japanese Kyowa Kirin acquires Orchard to bolster gene t...

The Japan-based pharmaceutical company Kyowa Kirin has entered into a defin...

AstraZeneca’s Forxiga meets primary endpoint for T2D

AstraZeneca has announced positive results from the T2NOW Phase III trial for p...

EMA endorses Calliditas’ Alport syndrome drug for orpha...

The European Medicines Agency (EMA) has provided a positive opinion for Callidi...

Inhibikase’s risvodetinib wins FDA orphan drug designation

The US Food and Drug Administration (FDA) has granted Inhibikase Therapeutics’ ...

Advanz Pharma to license Dimerix’s DMX-200 drug candidate

Advanz Pharma has signed an agreement to licence Dimerix’s drug candidate DMX-2...

Shorla raises funds to advance oncology drug candidates

US-Ireland speciality pharmaceutical company Shorla Oncology has received $35m ...

UK launches national full-body scan platform to acceler...

The UK national scanning programme, National PET Imaging Platform (NPIP), has b...

FDA issues draft guidance on stimulant use disorder dru...

The US Food and Drug Administration (FDA) has issued a draft guidance to aid sp...

ADCs dominate with billion-dollar licensing agreements ...

Antibody-drug conjugates (ADCs) saw a 400% growth in total licensing agreement ...

Understanding greenhouse gases in oil palm plantations

The rapid spread of oil palm plantations and associated high use of fertilizer r...

Say goodbye to the Covid-19 vaccination card. The CDC h...

It's the end of an era for a once-critical pandemic document: The ubiquitous whi...

STAT+: Was Amgen less than forthcoming about FDA’s conc...

Some analysts are questioning whether Amgen was fully forthcoming about a pricey...

STAT+: Federal bill would keep addiction medication fro...

A bill would address a Catch-22 in some pregnancies: use prescription medication...

Esketamine tops quetiapine for treatment-resistant depr...

Nasal esketamine spray is more effective than an extended-release antipsychotic,...